LONGMONT, Colo. , Feb. 6, 2024 /PRNewswire/ -- A Stony Brook University team of researchers led by Gábor Balázsi , PhD, has identified DNA amplification as a major cause of drug resistance in engineered mammalian cell lines and has ...
HR leaders believe early detection is the best way to combat costs and improve outcomes, but face challenges implementing benefits programs that address their needs and priorities BURLINGAME, Calif. , Feb. 6, 2024 /PRNewswire/ -- ...
ACE2016 Is an Allogeneic Gamma Delta 2 (?d2) T Cell Therapy Targeting the Epidermal Growth Factor Receptor (EGFR) in Patients With Solid Tumors. Phase 1 Clinical Study Expected to Begin in H2 2024. ALAMEDA, Calif. and TAIPEI , Feb. 4, ...
KRAKOW , Poland , Jan. 31, 2024 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced today ...
Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form. [1], [2] Pancreatic tumors are highly resistant to chemotherapy and radiation and there are ...
ARCADIA, Calif. , Jan. 29, 2024 /PRNewswire/ -- Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced that its sponsor client, CellVax Therapeutics Inc., received clearance of its ...
NEW YORK , Jan. 29, 2024 /PRNewswire/ -- Leal Health ("Leal" or "the Company"), formerly known as Trialjectory, a patient-first, AI-powered treatment platform revolutionizing patient access to cancer care, announced today that the ...
SHANGHAI , Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary ...
SHANGHAI , Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary ...
SHANGHAI , Jan. 25, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary ...
Radiation therapy for prostate cancer often induces notable side effects among men, including fatigue, sleep disturbances, and feelings of anxiety and depression. However, incorporating mindfulness audio recordings into their treatment regimen has ...
A trial of the world's premier "personalized" mRNA vaccine targeting melanoma, the deadliest form of skin cancer , has commenced in the UK, marking a significant stride in oncological research and treatment ( ). Steve Young, a ...
Mice fed a vitamin D-rich diet displayed enhanced immune resistance against experimentally transplanted cancers and showed improved responses to immunotherapy. Similar outcomes were observed when a protein binding vitamin D in the blood, thus ...
The research has revealed the considerable potential of tai chi as a non-pharmacological approach to improve survival rates in advanced lung cancer patients. It underscores the importance of incorporating ...
New research analyzing data from nearly 600,000 cancer patients in England reveals that survivors of breast cancer face a heightened risk of developing secondary...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers